Temporal trends in antithrombotic treatment of real-world UK patients with newly diagnosed atrial fibrillation: findings from the GARFIELD-AF registry

Objective To investigate evolving patterns in antithrombotic treatment in UK patients with newly diagnosed non-valvular atrial fibrillation (AF). Design Prospective, multicentre, international registry. Setting...

Full description

Bibliographic Details
Main Authors:	Apenteng, P, Gao, H, Hobbs, F, Fitzmaurice, D
Format:	Journal article
Published:	BMJ Publishing Group Ltd 2018

Similar Items

Temporal trends in antithrombotic treatment of real-world UK patients with newly diagnosed atrial fibrillation: findings from the GARFIELD-AF registry
by: Apenteng, P, et al.
Published: (2018)

Evolving antithrombotic treatment patterns in patients with newly diagnosed atrial fibrillation: UK findings from the GARFIELD-AF registry
by: Apenteng, P, et al.
Published: (2016)

Two-year outcomes of UK patients newly diagnosed with atrial fibrillation: findings from the prospective observational cohort study GARFIELD-AF
by: Apenteng, PN, et al.
Published: (2022)

33Patterns of antithrombotic therapy in relation to type of atrial fibrillation: insights from the UK cohort of the global GARFIELD registry.
by: Apenteng, P, et al.
Published: (2014)

An international longitudinal registry of patients with atrial fibrillation at risk of stroke (GARFIELD): the UK protocol.
by: Apenteng, P, et al.
Published: (2013)

Rhythm versus rate control in patients with newly diagnosed atrial fibrillation – Observations from the GARFIELD-AF registry
by: Marita Knudsen Pope, et al.
Published: (2023-12-01)

Healthcare Resource Utilization in Patients with Newly Diagnosed Atrial Fibrillation: A Global Analysis from the GARFIELD-AF Registry
by: Lorenzo G. Mantovani, et al.
Published: (2023-02-01)

Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry.
by: Ajay K Kakkar, et al.
Published: (2013-01-01)

Association of body mass index with outcomes in patients with newly diagnosed atrial fibrillation: GARFIELD-AF
by: Daniela Poli, et al.
Published: (2022-08-01)

Characteristics, treatment, and outcomes of newly diagnosed atrial fibrillation patients with heart failure: GARFIELD‐AF
by: Giuseppe Ambrosio, et al.
Published: (2021-04-01)

Risk profile, antithrombotic treatment and clinical outcomes of patients in Nordic countries with atrial fibrillation – results from the GARFIELD-AF registry
by: Marita Knudsen Pope, et al.
Published: (2021-01-01)

Do baseline characteristics and treatments account for geographical disparities in the outcomes of patients with newly diagnosed atrial fibrillation? The prospective GARFIELD-AF registry
by: Jonathan P Piccini, et al.
Published: (2022-01-01)

Management and 1‐Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD‐AF Registry
by: Shinya Goto, et al.
Published: (2019-02-01)

Changes in anticoagulant prescription in Dutch patients with recent-onset atrial fibrillation: observations from the GARFIELD-AF registry
by: J. Seelig, et al.
Published: (2020-03-01)

Real world time trends in antithrombotic treatment for newly diagnosed atrial fibrillation in China: reports from the GLORIA-AF Phase III registry
by: Xiaoxia Liu, et al.
Published: (2023-08-01)

Determinants and clinical outcomes of patients who refused anticoagulation: findings from the global GARFIELD-AF registry
by: Ajay K Kakkar, et al.
Published: (2023-02-01)

Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation.
by: Jean-Pierre Bassand, et al.
Published: (2018-01-01)

Garfield AF registry – Sub analysis of Indian data
by: J.P.S. Sawhney, et al.
Published: (2017-11-01)

Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry.
by: Sylvia Haas, et al.
Published: (2016-01-01)

Evolution of antithrombotic therapy for patients with atrial fibrillation: The prospective global GLORIA-AF registry program.
by: Lea Beier, et al.
Published: (2022-01-01)

Evolution of antithrombotic therapy for patients with atrial fibrillation: The prospective global GLORIA-AF registry program
by: Lea Beier, et al.
Published: (2022-01-01)

Clinical performance of the atrial fibrillation in the Russian population depending on the antithrombotic therapy: findings from the GLORIA-AF registry phase 2
by: E. V. Shlyakhto, et al.
Published: (2020-12-01)

PATIENTS WITH ATRIAL FIBRILLATION AND ISCHEMIC HEART DISEASE: HOSPITALIZATION STRUCTURE AND ANTITHROMBOTIC THERAPY (RECVASA AF-KURSK REGISTRY)
by: V. P. Mikhin, et al.
Published: (2017-05-01)

Atrial fibrillation and comorbidities: Clinical characteristics and antithrombotic treatment in GLORIA-AF.
by: Monika Kozieł, et al.
Published: (2021-01-01)

Sex-gender and atrial fibrillation treatment in the AntiThrombotic Agents in Atrial Fibrillation (ATA-AF) study
by: Cecilia Politi, et al.
Published: (2016-02-01)

Analysis of antithrombotic therapy of atrial fibrillation in international and Russian registries
by: O. V. Reshetko, et al.
Published: (2019-08-01)

Management of patients with newly-diagnosed atrial fibrillation: Insights from the BALKAN-AF survey
by: Monika Kozieł, et al.
Published: (2020-02-01)

Predicting Bleeding Events in Anticoagulated Patients With Atrial Fibrillation: A Comparison Between the HAS‐BLED and GARFIELD‐AF Bleeding Scores
by: Marco Proietti, et al.
Published: (2018-09-01)

Mineralocorticoid Receptor Antagonism in Patients With Atrial Fibrillation: Findings From the ORBIT‐AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) Registry
by: Marat Fudim, et al.
Published: (2018-04-01)

Antithrombotic treatment pattern in newly diagnosed atrial fibrillation patients and 2-year follow-up results for dabigatran-treated patients in the Africa/Middle-East Region: Phase II results from the GLORIA-AF registry program
by: Rabih R. Azar, et al.
Published: (2021-06-01)

Temporal Trends of Antithrombotic Therapy in Patients With Acute Myocardial Infarction and Atrial Fibrillation: Insight From the KAMIR-NIH Registry
by: Oh-Hyun Lee, et al.
Published: (2021-11-01)

Current use of direct oral anticoagulants for atrial fibrillation in Japan: Findings from the SAKURA AF Registry
by: Yasuo Okumura, et al.
Published: (2017-08-01)

THE EVALUATION OF ANTITHROMBOTIC TREATMENT PRESCRIPTION DYNAMICS IN PATIENTS WITH ATRIAL FIBRILLATION BY THE DATA OF PROFILE REGISTRY
by: S. Yu. Martsevich, et al.
Published: (2015-02-01)

Symptomatic and Asymptomatic Patients in the Polish Atrial Fibrillation (POL-AF) Registry
by: Marek Kiliszek, et al.
Published: (2021-03-01)

Age-dependent risk for thromboembolism in atrial fibrillation: The Fushimi AF registry
by: Masahiro Esato, et al.
Published: (2022-08-01)

Newly Diagnosed Atrial Fibrillation in Acute Myocardial Infarction
by: Yuki Obayashi, et al.
Published: (2021-09-01)

Predictors of Cardioembolic Stroke in Japanese Patients with Atrial Fibrillation in the Fushimi AF Registry
by: Ken Yasuda, et al.
Published: (2018-05-01)

Use of Oral Anticoagulants in Patients with Atrial Fibrillation: Preliminary Data from the Italian Atrial Fibrillation (ITALY-AF) Registry
by: Fabio Angeli, et al.
Published: (2023-09-01)

Choosing antithrombotics for atrial fibrillation in primary care
by: Mustafa, M, et al.
Published: (2020)

Anticoagulant management in patients with atrial fibrillation.
by: Fitzmaurice, D, et al.
Published: (2009)